VOR Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 23:00):

Stats
Dzisiejszy wolumen	138 367
Średni wolumen	336 337
Kapitalizacja rynkowa	122.79M
EPS	$0 ( 2024-03-28 )
Następna data zysków	( $-0.370 ) 2024-05-09
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.030
ATR14	$0.00500 (0.28%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Ang Robert	Sell	2 751	Common Stock
2024-05-01	Attar Eyal C.	Sell	1 146	Common Stock
2024-05-01	Jorgensen Nathan D.	Sell	917	Common Stock
2024-05-01	Chakraborty Tirtha	Sell	985	Common Stock
2024-04-30	Namouni Fouad	Buy	60 000	Stock Option (right to buy)

INSIDER POWER
97.37
Last 98 transactions
Buy: 33 390 275 \| Sell: 91 899 640

Wolumen Korelacja

Długi: -0.03 (neutral)

Krótki: -0.39 (neutral)

Signal:(53.375) Neutral

Vor Biopharma Inc. Korelacja

10 Najbardziej pozytywne korelacje
BNIXU	0.936
NUTX	0.88
WEN	0.85
GLMD	0.847
SBEAU	0.833
ATIF	0.816
BGNE	0.806
FRAF	0.801
KTRA	0.801

10 Najbardziej negatywne korelacje
WTER	-0.873
HOOK	-0.827
SLDP	-0.82
GSM	-0.816
MTEK	-0.815
PMD	-0.815
GRAY	-0.802

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Vor Biopharma Inc. Korelacja - Waluta/Towar

-0.24
( neutral )

-0.12
( neutral )

0.00
( neutral )

-0.05
( neutral )

Vor Biopharma Inc. Finanse

Annual	2023
Przychody:	$0
Zysk brutto:	$-3.49M (0.00 %)
EPS:	$-1.750

FY	2023
Przychody:	$0
Zysk brutto:	$-3.49M (0.00 %)
EPS:	$-1.750

FY	2022
Przychody:	$0
Zysk brutto:	$-8.96M (0.00 %)
EPS:	$-2.29

FY	2021
Przychody:	$0.00
Zysk brutto:	$0.00 (0.00 %)
EPS:	$0

Financial Reports:

No articles found.

Vor Biopharma Inc.

Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a collaboration agreement with Akron BioProducts to develop and manufacture cGMP nucleases. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts.

Aktualne aktualizacje dla Vor Biopharma Inc. [VOR]

Upcoming Earnings Alert